This stunning image features a deep field view of the Cassiopeia constellation where the two small planetary nebulas can be ...

The development comes after the Bureau of Indian Standards’ (BIS) recently carried out search and seizure operations at ...

China's increased gold reserves and U.S. foreign policy under Trump further fueled gold's bullish rally, benefiting Iamgold's stock price. IAMGOLD Corporation (NYSE:IAG) is a gold mining company ...

Like other fund managers, Nathan Rawlins has been fielding calls from clients concerned about economic uncertainty amid tariff headlines, "wondering when the market environment will turn, if it'll ...

As of the last trading session, the stock closed at $13.2 ... Let us evaluate and find out which card investors should play. Cut back on U.S. government spending stands as the greatest risk ...

The Indian stock market saw significant declines on March 4, with key stocks like Hindustan Unilever and Nestle India hitting 52-week lows.(PTI) Angel One, Birla Corporation, Cello World ...

Kotak Small Cap Fund (G) 166.47 25,49,768 1.01 Kotak Small Cap Fund - Direct (G) 166.47 25,49,768 1.01 Kotak Small Cap Fund - Direct (IDCW) 166.47 25,49,768 1.01 Canara Robeco Emerging Equities (G) ...

Bobby Deol aims to break away from being typecast in negative roles despite the success of 'Aashram'. Crediting Prakash Jha for changing perceptions, Deol appreciates the positive reception and ...

Nvidia's stock saw the pressure build as Thursday's session wore on, resulting in its worst post-earnings performance in more than six years. The stock ended the day off 8.5%, which was its ...

It will be wise to hold your position in this Zacks Rank #3 stock. Investors can wait and look for a better entry point post the fourth-quarter earnings. Our team of experts has just released the ...

Bloom Energy Corporation BE is expected to report an improvement in its top and bottom lines when it reports fourth-quarter 2024 results on Feb. 27, after market close. The Zacks Consensus ...

The stock trades at $11.00 a share, translating to an approximate market capitalization of $600 million. The company's commercial therapy is Hemgenix, which was approved by the FDA in November ...